Susquehanna Fundamental Investments, LLC Dexcom Inc Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$59.83 - $87.57 $3.53 Million - $5.17 Million	-59,011 Reduced 36.18%	104,081 $9.09 Million
Q1 2025 May 14, 2025	SELL	$67.74 - $90.75 $9.44 Million - $12.6 Million	-139,366 Reduced 46.08%	163,092 $11.1 Million
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $17.7 Million - $21.8 Million	269,577 Added 819.86%	302,458 $23.5 Million
Q2 2024 Aug 15, 2024	BUY	$110.31 - $140.45 $3.63 Million - $4.62 Million	32,881 New	32,881 $3.73 Billion
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $2.87 Million - $3.82 Million	-35,387 Closed	0 $0

Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $969,912 - $1.2 Million	-11,439 Reduced 24.43%	35,387 $12.7 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $3.65 Million - $4.89 Million	46,826 New	46,826 $17.3 Million

1,083

377M

6.76M

7.24M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.